104 related articles for article (PubMed ID: 1448405)
21. Computed tomography, magnetic resonance imaging and positron emission tomography in non-Hodgkin's lymphoma.
Rodriguez M
Acta Radiol Suppl; 1998; 417():1-36. PubMed ID: 9645167
[TBL] [Abstract][Full Text] [Related]
22. Cardiac localization of non-Hodgkin's lymphoma: two case reports and review of the literature.
Delmas-Marsalet B; Molinie V; Jary L; Teillet-Thiebaud F; Estagnasie P; Barge J; Teillet F
Nouv Rev Fr Hematol (1978); 1995; 37(4):223-30. PubMed ID: 8904202
[TBL] [Abstract][Full Text] [Related]
23. MR imaging of primary non-Hodgkin's breast lymphoma. A case report.
Mussurakis S; Carleton PJ; Turnbull LW
Acta Radiol; 1997 Jan; 38(1):104-7. PubMed ID: 9059411
[TBL] [Abstract][Full Text] [Related]
24. Primary pancreatic and renal non-Hodgkin's lymphoma: CT and MR findings.
Peeters E; Op de Beeck B; Osteaux M
JBR-BTR; 2001 Jun; 84(3):108-10. PubMed ID: 16619695
[TBL] [Abstract][Full Text] [Related]
25. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.
Carella AM; Cavaliere M; Lerma E; Ferrara R; Tedeschi L; Romanelli A; Vinci M; Pinotti G; Lambelet P; Loni C; Verdiani S; De Stefano F; Valbonesi M; Corsetti MT
J Clin Oncol; 2000 Dec; 18(23):3918-24. PubMed ID: 11099321
[TBL] [Abstract][Full Text] [Related]
26. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
[TBL] [Abstract][Full Text] [Related]
27. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
28. The significance of a residual mediastinal mass following treatment for aggressive non-Hodgkin's lymphomas.
Tredaniel J; Brice P; Lepage E; Bris C; Marolleau JP; Ferme C; Hennequin C; Fermand JP; Frija J; Gisselbrecht C
Eur Respir J; 1992 Feb; 5(2):170-3. PubMed ID: 1559581
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantation.
Jabbour E; Peslin N; Arnaud P; Ferme C; Carde P; Vantelon JM; Bocaccio C; Bourhis JH; Koscielny S; Ribrag V
Leuk Lymphoma; 2005 Jun; 46(6):861-7. PubMed ID: 16019530
[TBL] [Abstract][Full Text] [Related]
30. Value of imaging for the diagnosis of residual mediastinal mass in malignant lymphomas.
Brice P; Rain JD; Frija J
Nouv Rev Fr Hematol (1978); 1991; 33(6):531-2. PubMed ID: 1818310
[TBL] [Abstract][Full Text] [Related]
31. Fertility status among women treated for aggressive non-Hodgkin's lymphoma.
Elis A; Tevet A; Yerushalmi R; Blickstein D; Bairy O; Dann EJ; Blumenfeld Z; Abraham A; Manor Y; Shpilberg O; Lishner M
Leuk Lymphoma; 2006 Apr; 47(4):623-7. PubMed ID: 16690520
[TBL] [Abstract][Full Text] [Related]
32. Primary non-Hodgkin's lymphoma of the central nervous system.
Chin HW; Chin RY; Mansouri A; Ampil FL; Bahrassa FS
J La State Med Soc; 1993 Jan; 145(1):21-4. PubMed ID: 8423411
[TBL] [Abstract][Full Text] [Related]
33. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
34. Non-Hodgkin's lymphoma among the gamut of differential diagnoses for shoulder pain.
Guven GS; Solak Y; Unal O; Ozçakar L
Rheumatol Int; 2005 Sep; 25(7):565-6. PubMed ID: 15959785
[No Abstract] [Full Text] [Related]
35. Clinical and pathological features of 14 non-Hodgkin's lymphomas associated with coeliac disease.
Sonet A; Théate I; Delos M; Montfort L; Mineur P; Driesschaert P; Michaux L; Ferrant A; Bosly A
Acta Clin Belg; 2004; 59(3):143-51. PubMed ID: 15462511
[TBL] [Abstract][Full Text] [Related]
36. Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.
Horning SJ; Negrin RS; Chao JC; Long GD; Hoppe RT; Blume KG
J Clin Oncol; 1994 Dec; 12(12):2552-8. PubMed ID: 7989928
[TBL] [Abstract][Full Text] [Related]
37. [Imaging of renal graft lymphomas. Apropos of 5 cases].
Greget M; Veillon F; Ellero B; Tongio J; Wolf P
J Radiol; 1997 Nov; 78(11):1153-7. PubMed ID: 9499953
[TBL] [Abstract][Full Text] [Related]
38. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
[TBL] [Abstract][Full Text] [Related]
39. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
[TBL] [Abstract][Full Text] [Related]
40. Primary non-Hodgkin's lymphoma of bone: a rare disorder with high frequency of T-cell phenotype in southern Taiwan.
Hsieh PP; Tseng HH; Chang ST; Fu TY; Lu CL; Chuang SS
Leuk Lymphoma; 2006 Jan; 47(1):65-70. PubMed ID: 16321829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]